How has Comstock Inc.'s bioleum — research and development expense changed year-over-year?

Comstock Inc.'s bioleum — research and development expense decreased by 5.2% year-over-year, from $2.15M to $2.04M.

What does bioleum — research and development expense mean?

Represents expenditures dedicated to the innovation, design, and testing of new technologies or processes within the Bioleum segment. High levels of this expense indicate a focus on long-term technological advancement and future product viability.

Comstock Inc. LODE Bioleum — Research And Development Expense

Other segment segments

Corporate And Other

$162.1K-37.6%

Similar metrics at other companies

TMOLaboratory Products and Biopharma Services — Research and development expenses

$15M+15.4%

BDXBioPharma Systems — Research and development expense

$17M-5.6%

IFFHealth & Biosciences — Research and development expenses

$55M+5.8%

ASHLife Sciences — Research And Development Expense

$3M-25.0%

PFEBiopharma — Research and development expenses

$2.14B+10.1%

GLW

GLWLife Sciences and Emerging Growth Businesses — Research, development and engineering expenses

$28M-6.7%

Other financials

Income statement

See full

Revenue$313.5K-60.1%

Gross profit-$286.4K-184%

Operating income-$8.9M-27.1%

Net income-$9.4M-3.2%

EPS (diluted)-$3.01-450%

Balance sheet

See full

Cash & equivalents$53.0M+212%

Total debt$257.3K-98.8%

Total equity$156.4M—

Total assets$218.1M+28.6%

Cash flow

See full

Operating cash flow-$5.8M-17.3%

CapEx--100%

Free cash flow-$3.5M+2.7%

Valuation

See full

Market cap$302.13M+177%

Enterprise value$249.42M+118%

P/S279.4×+247×

Profitability

See full

Gross margin-116.4%-177pp

Operating margin-3,703.7%-7,510pp

Net margin-4,010%-13,152pp

FCF margin-462.3%-171pp

Returns & leverage

See full

Return on equity-51.5%-12.9pp

Debt / equity0×—

Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — research and development expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Comstock Inc.'s bioleum — research and development expense?: Comstock Inc. (LODE) reported bioleum — research and development expense of $2.04M in Q1 2026.
How has Comstock Inc.'s bioleum — research and development expense changed year-over-year?: Comstock Inc.'s bioleum — research and development expense decreased by 5.2% year-over-year, from $2.15M to $2.04M.
What does bioleum — research and development expense mean?: Represents expenditures dedicated to the innovation, design, and testing of new technologies or processes within the Bioleum segment. High levels of this expense indicate a focus on long-term technological advancement and future product viability.